Adc Therapeutics Sa ADCT Prévision boursière
Prédiction de prix et analyse propulsées par l'IA pour Adc Therapeutics Sa · Mise à jour Aoû 04, 2026
Prévision IA à 90 jours
CONSERVER
7 jours
30 jours
90 jours
Confiance de l'IA: -18% Corrélation de Spearman
août 04, 2026
Voir l'objectif de prix exact de ADCT
Créez un compte gratuit et suivez cette action pour débloquer ses prévisions IA complètes — 3 actions gratuites.
Inscrivez-vous gratuitement avec Google✓ Compte gratuit · ✓ Essai de 30 jours · ✓ Annuler à tout moment
Graphique des prix
Chargement du graphique...
Statistiques clés
Capitalisation boursière
$140M
Chiffre d'affaires
$79M
Ratio de liquidité générale
4,09x
Ratio D/CP
-2,35x
À propos de Adc Therapeutics Sa
Adc Therapeutics Sa (ADCT) opère dans le secteur Life Sciences, spécifiquement dans le secteur Pharmaceutical Preparations. .
Israel had more companies listed in 2012 on the NASDAQ stock exchange than any country outside of the United States and China. As of 2011, some sixty Israeli companies are listed on the Nasdaq. 2000 was the year that saw the most new Israeli listings on the exchange – 33 companies. Through the years, many have been acquired, merged with other companies, privatized, or gone out of business. Since the 1980s, over 250 Israeli companies had an initial public offering …
Dernières actualités
Pharmaceutical Preparations Entreprises comparables
| Entreprise | Ticker | Signal IA | Capitalisation boursière | P/E |
|---|---|---|---|---|
| Aardvark Therapeutics, Inc. | AARD | ██% | $158M | -x |
| Abbvie Inc. | ABBV | ██% | $431.12B | 68,3x |
| Abcellera Biologics Inc. | ABCL | ██% | $1.85B | -x |
| Abeona Therapeutics Inc. | ABEO | ██% | $388M | 5,9x |
| Abbott Laboratories | ABT | ██% | $183.69B | 29,3x |
| Arbutus Biopharma Corp | ABUS | ██% | $871M | 5,4x |
| Abvc Biopharma, Inc. | ABVC | ██% | $28M | -x |
| Abivax S.A. | ABVX | ██% | $9.83B | -x |
| Acadia Pharmaceuticals Inc | ACAD | ██% | $4.64B | 12,4x |
| Adicet Bio, Inc. | ACET | ██% | $86M | -x |
| Aclaris Therapeutics, Inc. | ACRS | ██% | $835M | -x |
| Acrivon Therapeutics, Inc. | ACRV | ██% | $60M | -x |
| Accustem Sciences Inc. | ACUT | ██% | $3M | -x |
| Acurx Pharmaceuticals, Inc. | ACXP | ██% | $6M | -x |
| Adagene Inc. | ADAG | ██% | $240M | -x |
| Adc Therapeutics Sa | ADCT | ██% | $140M | -x |
| Adial Pharmaceuticals, Inc. | ADIL | ██% | $8M | -x |
| Aditxt, Inc. | ADTX | ██% | $3M | -x |
| Addex Therapeutics Ltd. | ADXN | ██% | $7M | -x |
| Aeon Biopharma, Inc. | AEON | ██% | $13M | -x |
| Agios Pharmaceuticals, Inc. | AGIO | ██% | $1.88B | -x |
| Akebia Therapeutics, Inc. | AKBA | ██% | $354M | -x |
| Akari Therapeutics Plc | AKTX | ██% | $14M | -x |
| Aldeyra Therapeutics, Inc. | ALDX | ██% | $94M | -x |
| Alkermes Plc. | ALKS | ██% | $8.32B | 125,9x |
| Allarity Therapeutics, Inc. | ALLR | ██% | $21M | -x |
| Alumis Inc. | ALMS | ██% | $3.39B | -x |
| Alnylam Pharmaceuticals, Inc. | ALNY | ██% | $29.29B | 36,5x |
| Altimmune, Inc. | ALT | ██% | $597M | -x |
| Alx Oncology Holdings … | ALXO | ██% | $265M | -x |
| Alzamend Neuro, Inc. | ALZN | ██% | $7M | -x |
| Amylyx Pharmaceuticals, Inc. | AMLX | ██% | $2.43B | -x |
| Amphastar Pharmaceuticals, Inc. | AMPH | ██% | $888M | 11,2x |
| Amarin Corp Plc\Uk | AMRN | ██% | $302M | -x |
| Amneal Pharmaceuticals, Inc. | AMRX | ██% | $5.84B | 47,8x |
| Anaptysbio, Inc | ANAB | ██% | $1.60B | -x |
| Anebulo Pharmaceuticals, Inc. | ANEB | ██% | $13M | -x |
| Ani Pharmaceuticals Inc | ANIP | ██% | $1.66B | 18,0x |
| Anixa Biosciences Inc | ANIX | ██% | $116M | -x |
| Annexon, Inc. | ANNX | ██% | $812M | -x |
| Alto Neuroscience, Inc. | ANRO | ██% | $990M | -x |
| An2 Therapeutics, Inc. | ANTX | ██% | $214M | -x |
| Annovis Bio, Inc. | ANVS | ██% | $80M | -x |
| Apollomics Inc. | APLM | ██% | $39M | -x |
| Aprea Therapeutics, Inc. | APRE | ██% | $7M | -x |
| Apimeds Pharmaceuticals Us, … | APUS | ██% | $7M | -x |
| Aptevo Therapeutics Inc. | APVO | ██% | $5M | -x |
| Aquestive Therapeutics, Inc. | AQST | ██% | $465M | -x |
| Arcturus Therapeutics Holdings … | ARCT | ██% | $177M | -x |
| Ardelyx, Inc. | ARDX | ██% | $1.24B | -x |
| Arcutis Biotherapeutics, Inc. | ARQT | ██% | $3.25B | -x |
| Artelo Biosciences, Inc. | ARTL | ██% | $3M | -x |
| Arvinas, Inc. | ARVN | ██% | $588M | 63,2x |
| Arrowhead Pharmaceuticals, Inc. | ARWR | ██% | $12.64B | -x |
| Aspire Biopharma Holdings, … | ASBP | ██% | $9M | -x |
| Assembly Biosciences, Inc. | ASMB | ██% | $524M | -x |
| Ascendis Pharma A/S | ASND | ██% | $15.16B | -x |
| Assertio Holdings, Inc. | ASRT | ██% | $151M | -x |
| Atai Beckley N.V. | ATAI | ██% | $2.66B | -x |
| Alterity Therapeutics Ltd | ATHE | ██% | $80M | -x |
| Actinium Pharmaceuticals, Inc. | ATNM | ██% | $25M | -x |
| Atossa Therapeutics, Inc. | ATOS | ██% | $23M | -x |
| Avenue Therapeutics, Inc. | ATXI | ██% | $1M | -x |
| Aurinia Pharmaceuticals Inc. | AUPH | ██% | $1.95B | 6,6x |
| Arrivent Biopharma, Inc. | AVBP | ██% | $1.43B | -x |
| Atea Pharmaceuticals, Inc. | AVIR | ██% | $376M | -x |
| Avalo Therapeutics, Inc. | AVTX | ██% | $980M | -x |
| Axim Biotechnologies, Inc. | AXIM | ██% | $1M | -x |
| Axsome Therapeutics, Inc. | AXSM | ██% | $10.91B | -x |
| Azitra, Inc. | AZTR | ██% | $2M | -x |
| Bridgebio Pharma, Inc. | BBIO | ██% | $16.06B | -x |
| Bridgebio Oncology Therapeutics, … | BBOT | ██% | $710M | -x |
| Bicara Therapeutics Inc. | BCAX | ██% | $1.71B | -x |
| Briacell Therapeutics Corp. | BCTX | ██% | $29M | -x |
| Bicycle Therapeutics Plc | BCYC | ██% | $275M | -x |
| Bioadaptives, Inc. | BDPT | ██% | $30K | -x |
| Biodexa Pharmaceuticals Plc | BDRX | ██% | $1M | -x |
| Bullfrog Ai Holdings, … | BFRG | ██% | $11M | -x |
| Biofrontera Inc. | BFRI | ██% | $14M | -x |
| Bausch Health Companies … | BHC | ██% | $2.41B | -x |
| Bioharvest Sciences Inc. | BHST | ██% | $51M | -x |
| Bioage Labs, Inc. | BIOA | ██% | $497M | -x |
| Bio Essence Corp | BIOE | ██% | $13M | 9,7x |
| Sb Technology Holdings, … | BIOM | ██% | $330K | -x |
| Biovie Inc. | BIVI | ██% | $14M | -x |
| Bioxytran, Inc | BIXT | ██% | $2M | -x |
| Biolinerx Ltd. | BLRX | ██% | $12M | -x |
| Belite Bio, Inc | BLTE | ██% | $6.19B | -x |
| Biomea Fusion, Inc. | BMEA | ██% | $89M | -x |
| Biomarin Pharmaceutical Inc | BMRN | ██% | $11.74B | 43,7x |
| Bristol Myers Squibb … | BMY | ██% | $134.55B | 14,5x |
| Benitec Biopharma Inc. | BNTC | ██% | $430M | -x |
| Boundless Bio, Inc. | BOLD | ██% | $61M | -x |
| Bolt Biotherapeutics, Inc. | BOLT | ██% | $8M | -x |
| Bio-Path Holdings, Inc. | BPTH | ██% | $2M | -x |
| Bioquest Corp | BQST | ██% | $2M | -x |
| Barinthus Biotherapeutics Plc. | BRNS | ██% | $23M | -x |
| Bespoke Extracts, Inc. | BSPK | ██% | $10K | -x |
| Bioxcel Therapeutics, Inc. | BTAI | ██% | $27M | -x |
| Beyondspring Inc. | BYSI | ██% | $41M | -x |
| Calcimedica, Inc. | CALC | ██% | $13M | -x |
| Can-Fite Biopharma Ltd. | CANF | ██% | $7M | -x |
| Capricor Therapeutics, Inc. | CAPR | ██% | $240M | -x |
| Perspective Therapeutics, Inc. | CATX | ██% | $342M | -x |
| Gyre Therapeutics, Inc. | CBIO | ██% | $608M | -x |
| Cdt Equity Inc. | CDT | ██% | $2M | -x |
| Cingulate Inc. | CING | ██% | $66M | -x |
| Cell Source, Inc. | CLCS | ██% | $65M | -x |
| Clene Inc. | CLNN | ██% | $62M | -x |
| Cellectar Biosciences, Inc. | CLRB | ██% | $20M | -x |
| Clearside Biomedical, Inc. | CLSDQ | ██% | $1M | -x |
| Climb Bio, Inc. | CLYM | ██% | $719M | -x |
| Chemomab Therapeutics Ltd. | CMMB | ██% | $12M | -x |
| Clearmind Medicine Inc. | CMND | ██% | $3M | -x |
| Compass Pathways Plc | CMPS | ██% | $1.59B | -x |
| Cnbx Pharmaceuticals Inc. | CNBX | ██% | N/A | -x |
| Cns Pharmaceuticals, Inc. | CNSP | ██% | $8M | -x |
| Centessa Pharmaceuticals Plc | CNTA | ██% | $6.27B | -x |
| Connect Biopharma Holdings … | CNTB | ██% | $130M | -x |
| Context Therapeutics Inc. | CNTX | ██% | $57M | -x |
| Cocrystal Pharma, Inc. | COCP | ██% | $14M | -x |
| Cogent Biosciences, Inc. | COGT | ██% | $7.32B | -x |
| Collegium Pharmaceutical, Inc | COLL | ██% | $1.16B | 15,5x |
| Corcept Therapeutics Inc | CORT | ██% | $11.57B | 209,7x |
| Coya Therapeutics, Inc. | COYA | ██% | $107M | -x |
| China Pharma Holdings, … | CPHI | ██% | $48M | -x |
| Cumberland Pharmaceuticals Inc | CPIX | ██% | $116M | -x |
| Cannapharmarx, Inc. | CPMD | ██% | $1M | -x |
| Catalyst Pharmaceuticals, Inc. | CPRX | ██% | $3.85B | 17,4x |
| Corbus Pharmaceuticals Holdings, … | CRBP | ██% | $167M | -x |
| Cormedix Inc. | CRMD | ██% | $590M | 3,3x |
| Crinetics Pharmaceuticals, Inc. | CRNX | ██% | $8.87B | -x |
| Cervomed Inc. | CRVO | ██% | $26M | -x |
| Corvus Pharmaceuticals, Inc. | CRVS | ██% | $1.17B | -x |
| Cytomx Therapeutics, Inc. | CTMX | ██% | $723M | -x |
| Contineum Therapeutics, Inc. | CTNM | ██% | $596M | -x |
| Citius Oncology, Inc. | CTOR | ██% | $61M | -x |
| Ctt Pharmaceutical Holdings, … | CTTH | ██% | $4M | -x |
| Citius Pharmaceuticals, Inc. | CTXR | ██% | $17M | -x |
| Cue Biopharma, Inc. | CUE | ██% | $112M | -x |
| Curanex Pharmaceuticals Inc | CURX | ██% | $6M | -x |
| Cadrenal Therapeutics, Inc. | CVKD | ██% | $6M | -x |
| Cv Sciences, Inc. | CVSI | ██% | $4M | -x |
| Cyclerion Therapeutics, Inc. | CYCN | ██% | $15M | -x |
| Cytodyn Inc. | CYDY | ██% | $253M | -x |
| Cypherpunk Technologies Inc. | CYPH | ██% | $73M | -x |
| Cryoport, Inc. | CYRX | ██% | $764M | 9,6x |
| Cytokinetics Inc | CYTK | ██% | $10.67B | -x |
| Dare Bioscience, Inc. | DARE | ██% | $20M | -x |
| Decoy Therapeutics Inc. | DCOY | ██% | $2M | -x |
| Journey Medical Corp | DERM | ██% | $175M | -x |
| Diamedica Therapeutics Inc. | DMAC | ██% | $352M | -x |
| Damora Therapeutics, Inc. | DMRA | ██% | $1.85B | -x |
| Dianthus Therapeutics, Inc. … | DNTH | ██% | $6.05B | -x |
| Dermata Therapeutics, Inc. | DRMA | ██% | $4M | -x |
| Bright Minds Biosciences … | DRUG | ██% | $759M | -x |
| Design Therapeutics, Inc. | DSGN | ██% | $826M | -x |
| Dogwood Therapeutics, Inc. | DWTX | ██% | $60M | -x |
| Dyne Therapeutics, Inc. | DYN | ██% | $4.85B | -x |
| Emergent Biosolutions Inc. | EBS | ██% | $392M | -x |
| Edesa Biotech, Inc. | EDSA | ██% | $48M | -x |
| Pmgc Holdings Inc. | ELAB | ██% | $4M | -x |
| Elanco Animal Health … | ELAN | ██% | $12.78B | -x |
| Eledon Pharmaceuticals, Inc. | ELDN | ██% | $265M | -x |
| Elite Pharmaceuticals Inc … | ELTP | ██% | $389M | 8,7x |
| Elicio Therapeutics, Inc. | ELTX | ██% | $83M | -x |
| Enliven Therapeutics, Inc. | ELVN | ██% | $4.37B | -x |
| Emmaus Life Sciences, … | EMMA | ██% | $700K | -x |
| Enlivex Ltd. | ENLV | ██% | $36M | 0,0x |
| Ensysce Biosciences, Inc. | ENSC | ██% | $6M | -x |
| Enanta Pharmaceuticals Inc | ENTA | ██% | $387M | -x |
| Enveric Biosciences, Inc. | ENVB | ██% | $7M | -x |
| Evolus, Inc. | EOLS | ██% | $403M | -x |
| Eupraxia Pharmaceuticals Inc. | EPRX | ██% | $426M | -x |
| Equillium, Inc. | EQ | ██% | $143M | -x |
| Erasca, Inc. | ERAS | ██% | $6.38B | -x |
| Ernexa Therapeutics Inc. | ERNA | ██% | $5M | -x |
| Esperion Therapeutics, Inc. | ESPR | ██% | $799M | -x |
| Eton Pharmaceuticals, Inc. | ETON | ██% | $1.25B | -x |
| Earth Science Tech, … | ETST | ██% | $29M | 6,0x |
| Evofem Biosciences, Inc. | EVFM | ██% | $930K | -x |
| Evommune, Inc. | EVMN | ██% | $472M | -x |
| Edgewise Therapeutics, Inc. | EWTX | ██% | $4.80B | -x |
| Fortress Biotech, Inc. | FBIO | ██% | $90M | 0,7x |
| Fibrobiologics, Inc. | FBLG | ██% | $5M | -x |
| Forte Biosciences, Inc. | FBRX | ██% | $1.57B | -x |
| Foghorn Therapeutics Inc. | FHTX | ██% | $285M | -x |
| Filana Therapeutics, Inc. | FLNA | ██% | $48M | -x |
| Faeth Therapeutics, Inc. | FTH | ██% | $657M | -x |
| Fulcrum Therapeutics, Inc. | FULC | ██% | $290M | -x |
| Galectin Therapeutics Inc | GALT | ██% | $197M | -x |
| Gain Therapeutics, Inc. | GANX | ██% | $75M | -x |
| Greater Cannabis Company, … | GCAN | ██% | $260K | -x |
| Cytomed Therapeutics Ltd | GDTC | ██% | $10M | -x |
| Generate Biomedicines, Inc. | GENB | ██% | $1.83B | -x |
| Geron Corp | GERN | ██% | $875M | -x |
| Gh Research Plc | GHRS | ██% | $1.81B | -x |
| Galmed Pharmaceuticals Ltd. | GLMD | ██% | $5M | -x |
| Greenwich Lifesciences, Inc. | GLSI | ██% | $210M | -x |
| Genelux Corp | GNLX | ██% | $126M | -x |
| Genprex, Inc. | GNPX | ██% | $3M | -x |
| Gossamer Bio, Inc. | GOSS | ██% | $89M | -x |
| Geovax Labs, Inc. | GOVX | ██% | $4M | -x |
| Structure Therapeutics Inc. | GPCR | ██% | $3.53B | -x |
| Grace Therapeutics, Inc. | GRCE | ██% | $36M | -x |
| Gri Bio, Inc. | GRI | ██% | $3M | -x |
| Galera Therapeutics, Inc. | GRTX | ██% | $3.38B | 22,7x |
| Gsk Plc | GSK | ██% | $103.20B | -x |
| Gt Biopharma, Inc. | GTBP | ██% | $12M | -x |
| Gyre Therapeutics, Inc. | GYRE | ██% | $686M | -x |
| Hutchmed (China) Ltd | HCM | ██% | $2.01B | 2,2x |
| Hcw Biologics Inc. | HCWB | ██% | $6M | -x |
| Cybin Inc. | HELP | ██% | $575M | -x |
| Hepion Pharmaceuticals, Inc. | HEPA | ██% | $2M | -x |
| Vyome Holdings, Inc | HIND | ██% | $15M | -x |
| Hookipa Pharma Inc. | HOOK | ██% | $14M | -x |
| Werewolf Therapeutics, Inc. | HOWL | ██% | $20M | -x |
| Harmony Biosciences Holdings, … | HRMY | ██% | $2.25B | 12,4x |
| Heron Therapeutics, Inc. … | HRTX | ██% | $97M | -x |
| Hst Global, Inc. | HSTC | ██% | $99M | -x |
| Tuhura Biosciences, Inc./Nv | HURA | ██% | $133M | -x |
| Mindwalk Holdings Corp. | HYFT | ██% | $64M | -x |
| Hyperion Defi, Inc. | HYPD | ██% | $41M | -x |
| Ibio, Inc. | IBIO | ██% | $73M | -x |
| Impact Biomedical Inc. | IBO | ██% | $47M | -x |
| Ideaya Biosciences, Inc. | IDYA | ██% | $3.48B | -x |
| Inflarx N.V. | IFRX | ██% | $262M | -x |
| Igc Pharma, Inc. | IGC | ██% | $25M | -x |
| Immutep Ltd | IMMP | ██% | $57M | -x |
| Immix Biopharma, Inc. | IMMX | ██% | $664M | -x |
| Immunome Inc. | IMNM | ██% | $2.84B | -x |
| Imunon, Inc. | IMNN | ██% | $7M | -x |
| Immuron Ltd | IMRN | ██% | $9M | -x |
| Immuneering Corp | IMRX | ██% | $284M | -x |
| Immunic, Inc. | IMUX | ██% | $191M | -x |
| Integrated Biopharma Inc | INBP | ██% | $5M | -x |
| Indaptus Therapeutics, Inc. | INDP | ██% | $181M | -x |
| Indivior Pharmaceuticals, Inc. | INDV | ██% | $4.34B | 14,1x |
| Inmed Pharmaceuticals Inc. | INM | ██% | $8M | -x |
| Inovio Pharmaceuticals, Inc. | INO | ██% | $68M | -x |
| Insmed Inc | INSM | ██% | $21.38B | -x |
| Inhibitor Therapeutics, Inc. | INTI | ██% | $14M | -x |
| Innoviva, Inc. | INVA | ██% | $1.54B | 3,1x |
| Io Biotech, Inc. | IOBTQ | ██% | $10K | -x |
| Ionis Pharmaceuticals Inc | IONS | ██% | $9.12B | -x |
| Opus Genetics, Inc. | IRD | ██% | $306M | -x |
| Disc Medicine, Inc. | IRON | ██% | $2.98B | -x |
| Ironwood Pharmaceuticals Inc | IRWD | ██% | $709M | 6,9x |
| International Stem Cell … | ISCO | ██% | $2M | -x |
| Inventiva S.A. | IVA | ██% | $1.07B | -x |
| Incannex Healthcare Inc. | IXHL | ██% | $36M | -x |
| Jaguar Health, Inc. | JAGX | ██% | $5M | -x |
| Janux Therapeutics, Inc. | JANX | ██% | $971M | -x |
| Jazz Pharmaceuticals Plc | JAZZ | ██% | $16.53B | 17,6x |
| Jade Biosciences, Inc. | JBIO | ██% | $1.30B | -x |
| Johnson & Johnson | JNJ | ██% | $613.72B | 29,2x |
| Jupiter Neurosciences, Inc. | JUNS | ██% | $5M | -x |
| Kala Bio, Inc. | KALA | ██% | $14M | -x |
| Kalvista Pharmaceuticals, Inc. | KALV | ██% | $1.38B | -x |
| Kairos Pharma, Ltd. | KAPA | ██% | $7M | -x |
| Kaya Holdings, Inc. | KAYS | ██% | $210K | -x |
| Kamada Ltd | KMDA | ██% | $423M | -x |
| Kiniksa Pharmaceuticals International, … | KNSA | ██% | $5.81B | 79,6x |
| Kiora Pharmaceuticals Inc | KPRX | ██% | $10M | -x |
| Karyopharm Therapeutics Inc. | KPTI | ██% | $44M | -x |
| Keros Therapeutics, Inc. | KROS | ██% | $203M | -x |
| Korro Bio, Inc. | KRRO | ██% | $164M | -x |
| Pasithea Therapeutics Corp. | KTTA | ██% | $15M | -x |
| Kura Oncology, Inc. | KURA | ██% | $841M | -x |
| Kyntra Bio, Inc. | KYNB | ██% | $28M | 0,2x |
| Standard Biotools Inc. | LAB | ██% | $320M | 4,1x |
| Lb Pharmaceuticals Inc | LBRX | ██% | $1.29B | -x |
| Legend Biotech Corp | LEGN | ██% | $3.70B | -x |
| Lexaria Bioscience Corp. | LEXX | ██% | $9M | -x |
| Lifecore Biomedical, Inc. … | LFCR | ██% | $163M | -x |
| Lifevantage Corp | LFVN | ██% | $86M | 10,9x |
| Ligand Pharmaceuticals Inc | LGND | ██% | $6.02B | 39,2x |
| Longeveron Inc. | LGVN | ██% | $23M | -x |
| Lianbio | LIANY | ██% | $12M | -x |
| Lftd Partners Inc. | LIFD | ██% | $3M | -x |
| Lipella Pharmaceuticals Inc. | LIPO | ██% | $150K | -x |
| Lite Strategy, Inc. | LITS | ██% | $33M | -x |
| Lixte Biotechnology Holdings, … | LIXT | ██% | $120M | -x |
| Lakefront Biotherapeutics Nv | LKFT | ██% | $1.74B | -x |
| Eli Lilly & … | LLY | ██% | $997.98B | 39,5x |
| Lunai Bioworks Inc. | LNAI | ██% | $12M | -x |
| Lipocine Inc. | LPCN | ██% | $18M | -x |
| Liquidia Corp | LQDA | ██% | $7.80B | 349,9x |
| Larimar Therapeutics, Inc. | LRMR | ██% | $427M | -x |
| Lisata Therapeutics, Inc. | LSTA | ██% | $10M | -x |
| Lantern Pharma Inc. | LTRN | ██% | $35M | -x |
| Lexicon Pharmaceuticals, Inc. | LXRX | ██% | $1.06B | -x |
| Lyell Immunopharma, Inc. | LYEL | ██% | $317M | -x |
| Maia Biotechnology, Inc. | MAIA | ██% | $83M | -x |
| Veradermics, Inc | MANE | ██% | $4.48B | -x |
| Mustang Bio, Inc. | MBIO | ██% | $4M | -x |
| Moleculin Biotech, Inc. | MBRX | ██% | $3M | -x |
| Mbx Biosciences, Inc. | MBX | ██% | $3.36B | -x |
| Seres Therapeutics, Inc. | MCRB | ██% | $50M | -x |
| Medicus Pharma Ltd. | MDCX | ██% | $17M | -x |
| Madrigal Pharmaceuticals, Inc. | MDGL | ██% | $11.72B | -x |
| Scienture Holdings, Inc. | MEDS | ██% | $8M | -x |
| Macrogenics Inc | MGNX | ██% | $248M | -x |
| Mira Pharmaceuticals, Inc. | MIRA | ██% | $28M | -x |
| Mirum Pharmaceuticals, Inc. | MIRM | ██% | $6.36B | -x |
| Milestone Pharmaceuticals Inc. | MIST | ██% | $138M | -x |
| Moonlake Immunotherapeutics | MLTX | ██% | $1.53B | -x |
| Mineralys Therapeutics, Inc. | MLYS | ██% | $2.19B | -x |
| Mannkind Corp | MNKD | ██% | $1.22B | -x |
| Medicinova Inc | MNOV | ██% | $64M | -x |
| Monopar Therapeutics | MNPR | ██% | $794M | -x |
| Maplight Therapeutics, Inc. | MPLT | ██% | $585M | -x |
| Mereo Biopharma Group … | MREO | ██% | $51M | -x |
| Merck & Co., … | MRK | ██% | $316.42B | 35,4x |
| Marker Therapeutics, Inc. | MRKR | ██% | $21M | -x |
| Maravai Lifesciences Holdings, … | MRVI | ██% | $2.37B | -x |
| Satellos Bioscience Inc. | MSLE | ██% | $209M | -x |
| Matinas Biopharma Holdings, … | MTNB | ██% | $2M | -x |
| Metavia Inc. | MTVA | ██% | $8M | -x |
| Newamsterdam Pharma Co … | NAMS | ██% | $3.21B | -x |
| Natures Sunshine Products … | NATR | ██% | $359M | 18,1x |
| Novabridge Biosciences | NBP | ██% | $191M | -x |
| Nanobiotix S.A. | NBTX | ██% | $1.91B | -x |
| Newcelx Ltd. | NCEL | ██% | $19M | -x |
| Nucana Plc | NCNA | ██% | $6M | -x |
| Minerva Neurosciences, Inc. | NERV | ██% | $177M | -x |
| Neuphoria Therapeutics Inc. | NEUP | ██% | $21M | -x |
| Neurogene Inc. | NGNE | ██% | $686M | -x |
| Nika Pharmaceuticals, Inc | NIKA | ██% | $535M | -x |
| Nektar Therapeutics | NKTR | ██% | $2.46B | -x |
| Nkarta, Inc. | NKTX | ██% | $168M | -x |
| Nomad Power Solutions, … | NMAD | ██% | $68M | -x |
| Nanoviricides, Inc. | NNVC | ██% | $39M | -x |
| Nurix Therapeutics, Inc. | NRIX | ██% | $2.56B | -x |
| Neurosense Therapeutics Ltd. | NRSN | ██% | $19M | -x |
| Nrx Pharmaceuticals, Inc. | NRXP | ██% | $131M | -x |
| Nasus Pharma Ltd | NSRX | ██% | $41M | -x |
| Neonc Technologies Holdings, … | NTHI | ██% | $85M | -x |
| Nuvation Bio Inc. | NUVB | ██% | $2.23B | -x |
| Nuvalent, Inc. | NUVL | ██% | $9.75B | -x |
| Nuvectis Pharma, Inc. | NVCT | ██% | $655M | -x |
| Novartis Ag | NVS | ██% | $292.46B | -x |
| Northwest Biotherapeutics Inc | NWBO | ██% | $257M | -x |
| Nextcure, Inc. | NXTC | ██% | $24M | -x |
| Nexentis Technologies Inc. | NXTS | ██% | $3M | -x |
| Ocular Therapeutix, Inc | OCUL | ██% | $1.89B | -x |
| Oragenics Inc | OGEN | ██% | $2M | -x |
| Organigram Global Inc. | OGI | ██% | $140M | -x |
| Organon & Co. | OGN | ██% | $3.56B | 17,0x |
| Onkure Therapeutics, Inc. | OKUR | ██% | $166M | -x |
| Olema Pharmaceuticals, Inc. | OLMA | ██% | $1.03B | -x |
| Omeros Corp | OMER | ██% | $932M | 10,8x |
| Beone Medicines Ltd. | ONC | ██% | $33.51B | 51,1x |
| Onconetix, Inc. | ONCO | ██% | $3M | -x |
| Oncolytics Biotech Inc | ONCY | ██% | $94M | -x |
| Opko Health, Inc. | OPK | ██% | $989M | -x |
| Organogenesis Holdings Inc. | ORGO | ██% | $305M | 112,2x |
| Oric Pharmaceuticals, Inc. | ORIC | ██% | $1.40B | -x |
| Oruka Therapeutics, Inc. | ORKA | ██% | $5.92B | -x |
| Oramed Pharmaceuticals Inc. | ORMP | ██% | $183M | 1,7x |
| Os Therapies Inc | OSTX | ██% | $74M | -x |
| Oncotelic Therapeutics, Inc. | OTLC | ██% | $18M | -x |
| Ovid Therapeutics Inc. | OVID | ██% | $474M | -x |
| One World Products, … | OWPC | ██% | $110K | -x |
| Phibro Animal Health … | PAHC | ██% | $1.48B | 15,6x |
| Prestige Consumer Healthcare … | PBH | ██% | $2.52B | 13,2x |
| Psyence Biomedical Ltd. | PBM | ██% | $12M | -x |
| Puma Biotechnology, Inc. | PBYI | ██% | $397M | 16,3x |
| Pacira Biosciences, Inc. | PCRX | ██% | $1.10B | 75,1x |
| Processa Pharmaceuticals, Inc. | PCSA | ██% | $6M | -x |
| Procyon Corp | PCYN | ██% | $2M | -x |
| Pds Biotechnology Corp | PDSB | ██% | $40M | -x |
| Pepgen Inc. | PEPG | ██% | $133M | -x |
| Pfizer Inc | PFE | ██% | $144.81B | 33,4x |
| Precigen, Inc. | PGEN | ██% | $2.34B | -x |
| Phathom Pharmaceuticals, Inc. | PHAT | ██% | $677M | -x |
| Phio Pharmaceuticals Corp. | PHIO | ██% | $12M | -x |
| Pharvaris N.V. | PHVS | ██% | $2.37B | -x |
| Protokinetix, Inc. | PKTX | ██% | $3M | -x |
| Pliant Therapeutics, Inc. | PLRX | ██% | $65M | -x |
| Polaryx Therapeutics, Inc. | PLYX | ██% | $106M | -x |
| Polomar Health Services, … | PMHS | ██% | $4M | -x |
| Promis Neurosciences Inc. | PMN | ██% | $122M | -x |
| Pmv Pharmaceuticals, Inc. | PMVP | ██% | $62M | -x |
| Purple Biotech Ltd. | PPBT | ██% | $1M | -x |
| Propanc Biopharma, Inc. | PPCB | ██% | $2M | -x |
| Praxis Precision Medicines, … | PRAX | ██% | $8.64B | -x |
| Prf Technologies Ltd. | PRFX | ██% | $3M | -x |
| Perrigo Co Plc | PRGO | ██% | $1.49B | -x |
| Prelude Therapeutics Inc | PRLD | ██% | $373M | -x |
| Prophase Labs, Inc. | PRPH | ██% | $560K | -x |
| Proqr Therapeutics N.V. | PRQR | ██% | $258M | -x |
| Prothena Corp Public … | PRTA | ██% | $431M | -x |
| Ptc Therapeutics, Inc. | PTCT | ██% | $5.76B | -x |
| Protagonist Therapeutics, Inc | PTGX | ██% | $8.72B | -x |
| Protagenic Therapeutics, Inc.\New | PTIX | ██% | $410K | -x |
| Palatin Technologies Inc | PTN | ██% | $14M | -x |
| Petros Pharmaceuticals, Inc. | PTPI | ██% | $130K | 0,0x |
| Pulmatrix, Inc. | PULM | ██% | $6M | -x |
| Provectus Biopharmaceuticals, Inc. | PVCT | ██% | $25M | -x |
| Palvella Therapeutics, Inc. | PVLA | ██% | $2.03B | -x |
| Pyxis Oncology, Inc. | PYXS | ██% | $191M | -x |
| Quoin Pharmaceuticals, Ltd. | QNRX | ██% | $9M | -x |
| Quantum Biopharma Ltd. | QNTM | ██% | $18M | -x |
| Q32 Bio Inc. | QTTB | ██% | $480M | 14,2x |
| Quantum Cyber N.V. | QUCY | ██% | $34M | -x |
| Uniqure N.V. | QURE | ██% | $2.75B | -x |
| Radiopharm Theranostics Ltd | RADX | ██% | $23M | -x |
| Rani Therapeutics Holdings, … | RANI | ██% | $113M | -x |
| Rapport Therapeutics, Inc. | RAPP | ██% | $2.02B | -x |
| Ultragenyx Pharmaceutical Inc. | RARE | ██% | $2.54B | -x |
| Rocket Pharmaceuticals, Inc. | RCKT | ██% | $375M | -x |
| Arcus Biosciences, Inc. | RCUS | ██% | $3.47B | -x |
| Dr Reddys Laboratories … | RDY | ██% | $10.10B | -x |
| Regeneron Pharmaceuticals, Inc. | REGN | ██% | $78.20B | 18,1x |
| Revelation Biosciences, Inc. | REVB | ██% | $4M | -x |
| Rafael Holdings, Inc. | RFL | ██% | $102M | -x |
| Regen Biopharma Inc | RGBP | ██% | $80K | -x |
| Rigel Pharmaceuticals Inc | RIGL | ██% | $689M | 1,9x |
| Rocket One Inc. | RKTO | ██% | $20M | -x |
| Relmada Therapeutics, Inc. | RLMD | ██% | $574M | -x |
| Rallybio Corp | RLYB | ██% | $84M | -x |
| Retrieve Medical Holdings, … | RMHI | ██% | $25M | -x |
| Rockwell Medical, Inc. | RMTI | ██% | $30M | -x |
| Cartesian Therapeutics, Inc. | RNAC | ██% | $230M | -x |
| Transcode Therapeutics, Inc. | RNAZ | ██% | $4M | -x |
| Rein Therapeutics, Inc. | RNTX | ██% | $65M | -x |
| Renovorx, Inc. | RNXT | ██% | $47M | -x |
| Roivant Sciences Ltd. | ROIV | ██% | $24.00B | -x |
| Royalty Pharma Plc | RPRX | ██% | $33.10B | 40,0x |
| Rest Ez Inc. | RTEZ | ██% | $1.93B | -x |
| Reviva Pharmaceuticals Holdings, … | RVPH | ██% | $7M | -x |
| Revium Rx. | RVRC | ██% | $101M | -x |
| Rhythm Pharmaceuticals, Inc. | RYTM | ██% | $7.28B | -x |
| Rezolute, Inc. | RZLT | ██% | $479M | -x |
| Sunshine Biopharma Inc. | SBFM | ██% | $3M | -x |
| Scienture Holdings, Inc. | SCNX | ██% | $15M | -x |
| Scynexis Inc | SCYX | ██% | $429M | -x |
| Stablecoin Development Corp | SDEV | ██% | $56M | 0,1x |
| Schrodinger, Inc. | SDGR | ██% | $1.16B | -x |
| Septerna, Inc. | SEPN | ██% | $1.75B | -x |
| Serina Therapeutics, Inc. | SER | ██% | $32M | -x |
| Sagimet Biosciences Inc. | SGMT | ██% | $493M | -x |
| Shuttle Pharmaceuticals Holdings, … | SHPH | ██% | $2M | -x |
| Siga Technologies Inc | SIGA | ██% | $230M | 11,4x |
| Silo Pharma, Inc. | SILO | ██% | $5M | -x |
| Sionna Therapeutics, Inc. | SION | ██% | $2.22B | -x |
| Skinvisible, Inc. | SKVI | ██% | $970K | -x |
| Skye Bioscience, Inc. | SKYE | ██% | $20M | -x |
| Sol-Gel Technologies Ltd. | SLGL | ██% | $266M | -x |
| Silence Therapeutics Plc | SLN | ██% | $528M | -x |
| Sellas Life Sciences … | SLS | ██% | $2.12B | -x |
| Summit Therapeutics Inc. | SMMT | ██% | $10.67B | -x |
| Semnur Pharmaceuticals, Inc. | SMNR | ██% | $200M | -x |
| Syndax Pharmaceuticals Inc | SNDX | ██% | $1.72B | -x |
| Soligenix, Inc. | SNGX | ██% | $6M | -x |
| Faeth Therapeutics, Inc. | SNSE | ██% | $31M | -x |
| Sanofi | SNY | ██% | $102.59B | -x |
| Spruce Biosciences, Inc. | SPRB | ██% | $123M | -x |
| Scisparc Ltd. | SPRC | ██% | $4M | -x |
| Spero Therapeutics, Inc. | SPRO | ██% | $69M | 4,6x |
| Ars Pharmaceuticals, Inc. | SPRY | ██% | $534M | -x |
| Sarepta Therapeutics, Inc. | SRPT | ██% | $1.68B | 25,8x |
| Stoke Therapeutics, Inc. | STOK | ██% | $1.87B | -x |
| Shattuck Labs, Inc. | STTK | ██% | $713M | -x |
| Supernus Pharmaceuticals, Inc. | SUPN | ██% | $2.55B | -x |
| Savara Inc | SVRA | ██% | $1.11B | -x |
| 60 Degrees Pharmaceuticals, … | SXTP | ██% | $3M | -x |
| Synlogic, Inc. | SYBX | ██% | $13M | -x |
| Spyre Therapeutics, Inc. | SYRE | ██% | $8.00B | -x |
| Takeda Pharmaceutical Co … | TAK | ██% | $52.71B | -x |
| Theravance Biopharma, Inc. | TBPH | ██% | $869M | 7,6x |
| Alaunos Therapeutics, Inc. | TCRT | ██% | $5M | -x |
| Telomir Pharmaceuticals, Inc. | TELO | ██% | $84M | -x |
| Tenax Therapeutics, Inc. | TENX | ██% | $496M | -x |
| Teva Pharmaceutical Industries … | TEVA | ██% | $39.91B | 56,5x |
| Tg Therapeutics, Inc. | TGTX | ██% | $7.02B | 15,2x |
| Talphera, Inc. | TLPH | ██% | $68M | -x |
| Telix Pharmaceuticals Ltd | TLX | ██% | $3.46B | -x |
| Tango Therapeutics, Inc. | TNGX | ██% | $4.60B | -x |
| Tonix Pharmaceuticals Holding … | TNXP | ██% | $180M | -x |
| Theriva Biologics, Inc. | TOVX | ██% | $10M | -x |
| Tempest Therapeutics, Inc. | TPST | ██% | $14M | -x |
| Entrada Therapeutics, Inc. | TRDA | ██% | $281M | -x |
| Trevi Therapeutics, Inc. | TRVI | ██% | $2.38B | -x |
| Turn Therapeutics Inc. | TTRX | ██% | $271M | -x |
| Tvardi Therapeutics, Inc. | TVRD | ██% | $19M | -x |
| Travere Therapeutics, Inc. | TVTX | ██% | $5.17B | -x |
| Therapeuticsmd, Inc. | TXMD | ██% | $24M | 133,8x |
| Tyra Biosciences, Inc. | TYRA | ██% | $1.94B | -x |
| Unicycive Therapeutics, Inc. | UNCY | ██% | $130M | -x |
| Upstream Bio, Inc. | UPB | ██% | $369M | -x |
| Urogen Pharma Ltd. | URGN | ██% | $1.96B | -x |
| United Therapeutics Corp | UTHR | ██% | $25.91B | 20,1x |
| Valion Bio, Inc. | VBIO | ██% | $1M | -x |
| Vaccinex, Inc. | VCNX | ██% | $3M | -x |
| Vera Therapeutics, Inc. | VERA | ██% | $2.23B | -x |
| Sb Technology Holdings, … | VGLS | ██% | $240K | -x |
| Vicapsys Life Sciences, … | VICP | ██% | $47M | -x |
| Viking Therapeutics, Inc. | VKTX | ██% | $3.88B | -x |
| Vanda Pharmaceuticals Inc. | VNDA | ██% | $324M | -x |
| Verrica Pharmaceuticals Inc. | VRCA | ██% | $94M | -x |
| Viridian Therapeutics, Inc.\De | VRDN | ██% | $2.06B | -x |
| Vireo Growth Inc. | VREOD | ██% | $491M | -x |
| Vireo Growth Inc. | VREOF | ██% | $491M | -x |
| Vertex Pharmaceuticals Inc … | VRTX | ██% | $120.64B | 27,8x |
| Verastem, Inc. | VSTM | ██% | $509M | -x |
| Vistagen Therapeutics, Inc. | VTGN | ██% | $11M | -x |
| Viatris Inc | VTRS | ██% | $20.36B | -x |
| Yarrow Bioscience, Inc. | VYNE | ██% | $19M | -x |
| Whitehawk Therapeutics, Inc. | WHWK | ██% | $195M | -x |
| Wave Life Sciences … | WVE | ██% | $1.15B | -x |
| Xenetic Biosciences, Inc. | XBIO | ██% | $6M | -x |
| Xbiotech Inc. | XBIT | ██% | $69M | -x |
| Exicure, Inc. | XCUR | ██% | $10M | -x |
| Xenon Pharmaceuticals Inc. | XENE | ██% | $6.15B | -x |
| Xeris Biopharma Holdings, … | XERS | ██% | $1.43B | 118,7x |
| Xilio Therapeutics, Inc. | XLO | ██% | $60M | -x |
| Xencor Inc | XNCR | ██% | $1.49B | -x |
| Xoma Royalty Corp | XOMA | ██% | $710M | 21,0x |
| Xtl Biopharmaceuticals Ltd | XTLB | ██% | $7M | -x |
| Zenas Biopharma, Inc. | ZBIO | ██% | $1.94B | -x |
| Zai Lab Ltd | ZLAB | ██% | $2.08B | -x |
| Zentalis Pharmaceuticals, Inc. | ZNTL | ██% | $337M | -x |
| Zoetis Inc. | ZTS | ██% | $31.95B | 12,1x |
| Zevra Therapeutics, Inc. | ZVRA | ██% | $608M | 4,9x |
| Zyversa Therapeutics, Inc. | ZVSA | ██% | $1M | -x |
FAQ
-
Adc Therapeutics Sa est-il une bonne action à acheter ?
Notre IA analyse Adc Therapeutics Sa quotidiennement. Consultez le signal ci-dessus pour la dernière recommandation. Effectuez toujours vos propres recherches avant d'investir.
-
Quelle est la précision des prédictions de Adc Therapeutics Sa ?
Notre IA atteint une corrélation de Spearman de -18% pour cette action, avec une précision moyenne supérieure à 67% sur plus de 4 000 actions analysées quotidiennement.
-
À quelle fréquence les prévisions sont-elles mises à jour ?
Les prévisions de Adc Therapeutics Sa sont mises à jour quotidiennement avec les dernières données de marché et les modèles d'IA.
Prêt à investir plus intelligemment ?
Rejoignez des milliers d'investisseurs utilisant des prédictions boursières propulsées par l'IA
Inscription gratuite✓ Compte gratuit · ✓ Plus de 4 000 actions · ✓ Mises à jour quotidiennes
Vous cherchez une analyse plus approfondie de Adc Therapeutics Sa ?
Voir l'analyse institutionnelle complète sur Intratio →Les prédictions IA sont basées sur des modèles historiques et ne doivent pas constituer la seule base pour les décisions d'investissement. Les performances passées ne garantissent pas les résultats futurs. Effectuez toujours vos propres recherches.